These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The number on biotech indexes. Jacobs T Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059 [No Abstract] [Full Text] [Related]
9. Biotech marks time in Q3. Lawrence S Nat Biotechnol; 2005 Nov; 23(11):1332. PubMed ID: 16273049 [No Abstract] [Full Text] [Related]
10. Tough times set to continue for US biotech start-ups. Lehrman S Nature; 1999 Jan; 397(6716):191. PubMed ID: 9930684 [No Abstract] [Full Text] [Related]
11. Biotech holds its own in Q2. Lawrence S Nat Biotechnol; 2004 Aug; 22(8):938. PubMed ID: 15286634 [No Abstract] [Full Text] [Related]
12. US government previews biotech survey. Goho A Nat Biotechnol; 2003 Aug; 21(8):837-8. PubMed ID: 12894185 [No Abstract] [Full Text] [Related]
13. Is your biotech giving away the store? Jacobs T Nat Biotechnol; 2002 Nov; 20(11):1079. PubMed ID: 12410245 [No Abstract] [Full Text] [Related]
14. Getting real about valuations in biotech. Villiger R; Bogdan B Nat Biotechnol; 2005 Apr; 23(4):423-8. PubMed ID: 15815665 [No Abstract] [Full Text] [Related]
16. Scientists and societies. The Polish biotech gap. Gorlach S; Slabicki M Nature; 2004 Feb; 427(6977):870. PubMed ID: 14985771 [No Abstract] [Full Text] [Related]
17. Biotech slumps in Q1. Lawrence S Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769 [No Abstract] [Full Text] [Related]
18. John McCamant on the future of biotech. Interview by Dennis Murray. McCamant J Med Econ; 2002 Jan; 79(1):43-6. PubMed ID: 11807995 [No Abstract] [Full Text] [Related]